Brett Reynolds has been appointed to succeed Mahedi Jiwani as chief financial officer at Uroplasty. Reynolds previously served as CFO for Synovis Life Technologies for nine years before he went on to lead the Minnesota site of Baxter Healthcare, which acquired Synovis for $325 million last year.
An FDA panel meeting to consider whether to continue to subject shortwave diathermy systems to the premarket approval process or recategorize them as Class I or II devices has been rescheduled for May 21. The panel will also meet May 22 to discuss the possible reclassification of pedicle screws, which are used in spinal fusion surgeries.
St. Jude Medical has secured approval in Europe to market its Brio, Ibra and LibraXP deep brain stimulators. The systems work by sending electrical signals to parts of the brain and are said to be the first such devices cleared for use in treating patients with primary and secondary dystonia, a neurological condition that triggers muscle spasms.
IRhythm Technologies has pulled in $15.1 million in an equity offering and hopes to raise $1.9 million more in that round. The San Francisco startup is the maker of the Zio patch, which the company said can monitor cardiac rhythm for a maximum of two weeks.
Altura Medical has obtained $6 million in an equity financing round aiming for $10 million. The San Clemente, Calif.-based startup is working on stent grafts that can be used to treat patients with aneurysms in the arterial vascular system.